The loudness dependence of auditory evoked potentials and effects of psychopathology and psychopharmacotherapy in psychiatric inpatients

Human Psychopharmacology

Volumn 27, Issue 6, 2012, Pages 595-604

  Ostermann, Julia ^a   Uhl, Idun ^a   Köhler, Elke ^a   Juckel, Georg ^a   Norra, Christine ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

affective disorder; depression; event related potentials (ERP); loudness dependence of auditory evoked potentials (LDAEP); schizophrenia; serotonin

Indexed keywords

ANTIHISTAMINIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; HYPNOTIC AGENT; MIRTAZAPINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; BRIEF SYMPTOM INVENTORY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LOUDNESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEASUREMENT; MENTAL DISEASE; MENTAL PATIENT; NEUROPHYSIOLOGY; OUTCOME ASSESSMENT; PARANOIA; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; NEUROTRANSMITTER UPTAKE INHIBITORS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 84868571006     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2269     Document Type: Article

References (57)

1. Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E,. 2001. Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. J Psychopharmacol 15: 237-242.
2. Aşçioglu M, Dolu N, Gölgeli A, Süer C, Ozesmi C,. 2004. Effects of cigarette smoking on cognitive processing. Int J Neurosci 114: 381-390.
3. Beck AT, Steer RA,. 1987. Beck Depression Inventory. Harcourt Brace Jovanovich: New York.
4. Benkert O, Hippius H,. 2011. Kompendium der Psychiatrischen Pharmakotherapie (8th edn). Springer Medizin Verlag: Berlin.
5. Buchsbaum MS, Henkin R, Christiansen R,. 1974. Age and sex differences in averaged evoked responses in a normal population with observations on patients with gonadal dysgenesis. Electroencephalogr Clin Neurophysiol 37: 137-144.
6. Debener S, Strobel A, Kürschner K, et al,. 2002. Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion? Biol Psychol 59: 121-133.
7. Derogatis, LR,. 1993. BSI Brief Symptom Inventory. Administration, Scoring, and Procedures Manual (4th edn). National Computer Systems: Minneapolis, MN.
8. Dierks T, Barta S, Demisch L, et al,. 1999. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology 146: 101-107.
9. Fisher DJ, Scott TL, Shah DK, Prise S, Thompson M, Knott V,. 2010. Light up and see: enhancement of the visual mismatch negativity (vMMN) by nicotine. Brain Res 1313: 162-171.
10. Fitzgerald PB, Mellow TB, Hoy KE, et al,. 2009. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. J Affect Dis 117: 212-216.
11. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ,. 2000. The loudness dependence of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology 148: 404-411.
12. Gallinat J, Kunz D, Lang UE, et al,. 2005. Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing. Pharmacopsychiatry 38: 158-160.
13. Gudlowski Y, Ozgürdal S, Witthaus H, et al,. 2009. Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 109: 141-147.
14. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ,. 2008. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 23: 231-241.
15. Hegerl U, Juckel G,. 1993. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33: 173-187.
16. Hegerl U, Gallinat J, Mrowinski D,. 1994. Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17: 1-13.
17. Hegerl U, Gallinat J, Juckel G,. 2001. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 62: 93-100.
18. Hensch T, Herold U, Brocke B,. 2007. An electrophysiological endophenotype of hypomanic and hyperthymic personality. J Affect Dis 101: 13-26.
19. Hensch T, Herold U, Diers K, Armbruster D, Brocke B,. 2008. Reliability of intensity dependence of auditory-evoked potentials. Clin Neurophysiol 119: 224-236.
20. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G,. 1999. Auditory evoked potentials reflect serotonergic neuronal activitya-a study in behaving cats administered drugs acting on 5-HT1A autoreceptors acting in the dorsal raphe nucleus. Neuropsychopharmacology 21: 710-716.
21. Juckel G, Gallinat J, Riedel M, et al,. 2003. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64: 115-124.
22. Juckel G, Pogarell O, Augustin H, et al,. 2007. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 68: 1206-1212.
23. Juckel G, Gudlowski Y, Müller D, et al,. 2008. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophreniaa-a replication study. Psychiatry Res 158: 79-82.
24. Knott VJ, Venables PH,. 1978. Stimulus intensity control and the cortical evoked response in smokers and non-smokers. Psychophysiology 15: 186-192.
25. Lee TW, Yu YW, Chen TJ, Tsai SJ,. 2005. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 30: 202-205.
26. Lee IH, Yang YK, Chen PS, et al,. 2011. Loudness dependence of auditory evoked potentials (LDAEP) correlates with the availability of dopamine transporters and serotonin transporters in healthy volunteersa-a two isotopes SPECT study. Psychopharmacology (Berl) 214: 617-624.
27. Linka T, Müller BW, Bender S, Sartory G, Gastpar M,. 2005. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 38: 139-143.
28. Linka T, Müller BW, Bender S, Sartory G,. 2004. The intensity dependence of the auditory evoked N1 component as a predictor of response to citalopram treatment in patients with major depression. Neurosci Lett 367: 375-378.
29. Linka T, Sartory G, Bender S, Gastpar M, Müller BW,. 2007. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy subjects. An analysis of group differences. J Affect Dis 103: 139-145.
30. Linka T, Sartory G, Gastpar M, Scherbaum N, Müller BW,. 2009a. Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components. Psychiatry Res 169: 139-143.
31. Linka T, Sartory G, Wiltfang J, Müller BW,. 2009b. Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression. Neurosci Lett 463: 26-30.
32. Manjarrez G, Hernandez E, Robles A, Hernandez J,. 2005. N1/P2 component of auditory evoked potential reflect changes of the brain serotonin biosynthesis in rats. Nutr Neurosci 8: 213-218.
33. Mavrogiorgou P, Gohle D, Winter C, et al,. 2010. Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disordera-an auditory evoked potential study. J Clin Psychopharmacol 30: 341-343.
34. McBride PA, Tierney H, DeMeo M, Chen JS, Mann JJ,. 1990. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27: 1143-1155.
35. Meltzer HY, Massey BW,. 2011. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 11: 59-67.
36. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ,. 2006. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21: 47-52.
37. Norra C, Mrazek M, Tuchtenhagen F, et al,. 2003. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiatr Res 37: 23-33.
38. Norra C, Becker S, Bröcheler A, Kawohl W, Kunert HJ, Buchner H,. 2008. Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 21: 31-42.
39. Norra C, Feilhauer J, Wiesmüller GA, Kunert HJ,. 2010. Differential effects of endogenous lithium on neurobehavioural functioning: a study on auditory evoked potentials. Psychiatry Res 178: 176-181.
40. Oliva J, Leung S, Croft RJ, et al,. 2010. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Hum Psychopharmacol 25: 423-427.
41. Oliva JL, Leung S, Croft RJ, O'Neill BV, Stout JC, Nathan PJ,. 2011. Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans. Hum Psychopharmacol 26: 172-176.
42. O'Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL,. 2006. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology 188: 92-99.
43. O'Neill BV, Guille V, Croft RJ, et al,. 2008. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacology 23: 301-312.
44. Paige SR, Fitzpatrick DF, Kline JP, Balogh SE, Hendricks SE,. 1994. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 30: 197-201.
45. Paige SR, Hendricks SE, Fitzpatrick DF, Balogh S, Burke WJ,. 1995. Amplitude/ intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharmacol Bull 31: 243-248.
46. Park YM, Lee SH, Kim S, Bae SM,. 2010. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 34: 313-316.
47. Park YM, Kim DW, Kim S, Im CH, Lee SH,. 2011. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl) 213: 625-632.
48. Pogarell O, Tatsch K, Juckel G, et al,. 2004. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuro-psychobiology 29: 1910-1917.
49. Preuss UW, Bondy B, Zill P, et al,. 2000. Possible association between loudness dependence of auditory evoked potentials and tryptophan hydroxylase-alleles in alcoholics. Addict Biol 5: 297-305.
50. Rosburg T, Marinou V, Haueisen J, Smesny S, Sauer H,. 2004. Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100m. Neuropsychopharmacology 29: 1723-1733.
51. Simmons JG, Nathan PJ, Berger G, Allen NB,. 2011. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology (Berl) 217: 101-110.
52. Tauscher J, Verhoeff NP, Christensen BK, et al,. 2001. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 24: 522-530.
53. Tuchtenhagen F, Daumann J, Norra C, et al,. 2000. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22: 608-617.
54. Uhl I, Gorynia I, Gallinat J, et al,. 2006. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21: 463-471.
55. Walpurger V, Pietrowsky R, Kirschbaum C, Wolf OT,. 2004. Effects of the menstrual cycle on auditory event-related potentials. Horm Behav 46: 600-606.
56. World Health Organization. 1991. Tenth Revision of the International Classification of Diseases, Chapter (V): Mental and Behavioural Disorders (including disorders of psychological development). WHO: Clinical Descriptions and Diagnostic Guidelines.
57. Wutzler A, Winter C, Kitzrow W, et al,. 2008. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 33: 3176-3181.